➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Merck
Dow
McKesson
Medtronic

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

Litigation Details for Valeant Pharmaceuticals International v. Actavis Laboratories FL, Inc. (D. Del. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Valeant Pharmaceuticals International v. Actavis Laboratories FL, Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Valeant Pharmaceuticals International v. Actavis Laboratories FL, Inc. (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 155 Opinion - Memorandum Opinion infringement of U.S. Patent Nos. 10,052,286 (the “’286 patent”), 10,064,878 (the “’878 patent”), 10,105,374986 patent (claims 1-22); °964 patent (claims 29-30); ’799 patent (claims 22-23). 15 °878 patent (claims…10,105,374 (the “’374 Patent”), 10,143,698 (the “’698 Patent”), 10,154,964 (the “964 Patent”), and 10,172,799 (… (the “’799 Patent”) (collectively “the patents-in- suit”). (D.L 1) These patents may be grouped into …matrix . . .”) (quoting °286 patent at 5:15-19; °374 patent at 5:17-21; 964 patent at 5:15-19; D.L. 134, Mullen External link to document
2019-10-28 161 SO ORDERED and continue to infringe U.S. Patent Nos. 10,052,286, 10,064,878, 10,105,374, 10,143,698, 10,154,964…the Patents-in-Suit, and have not induced and will not induce others to infringe the Patents-in-Suit…10,154,964, and l 0, 172,799 (collectively, the "Patents-in-Suit") by filing Actavis Laboratories …declaratory judgment of noninfringement of the Patents-in-Suit in Counts I, III, V, VII, IX, and XI of…for declaratory judgment of invalidity of the Patents-in-Suit in Counts II, IV, VI, VIII, X, and XII External link to document
0000-00-00 38 Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,052,286 B2 ;10,064,878 B2 . (Flynn…2018 28 October 2019 1:18-cv-01288 830 Patent Plaintiff District Court, D. External link to document
0000-00-00 67 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,064,878 B2 ;10,105,374 B2 …2018 28 October 2019 1:18-cv-01288 830 Patent Plaintiff District Court, D. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
AstraZeneca
Boehringer Ingelheim
Merck
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.